An overview of Leber congenital amaurosis: a model to understand human retinal development

Survey of Ophthalmology
Robert K Koenekoop

Abstract

Leber congenital amaurosis is a congenital retinal dystrophy described almost 150 years ago. Today, Leber congenital amaurosis is proving instrumental in our understanding of the molecular events that determine normal and aberrant retinal development. Six genes have been shown to be mutated in Leber congenital amaurosis, and they participate in a wide variety of retinal pathways: retinoid metabolism (RPE65), phototransduction (GUCY2D), photoreceptor outer segment development (CRX), disk morphogenesis (RPGRIP1), zonula adherens formation (CRB1), and cell-cycle progression (AIPL1). Longitudinal studies of visual performance show that most Leber congenital amaurosis patients remain stable, some deteriorate, and rare cases exhibit improvements. Histopathological analyses reveal that most cases have extensive degenerative retinal changes, some have an entirely normal retinal architecture, whereas others have primitive, poorly developed retinas. Animal models of Leber congenital amaurosis have greatly added to understanding the impact of the genetic defects on retinal cell death, and response to rescue. Gene therapy for RPE65 deficient dogs partially restored sight, and provides the first real hope of treatment for this devastating b...Continue Reading

References

May 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·J LemM I Simon
Jun 15, 1989·American Journal of Ophthalmology·S R LambertM Pembrey
Apr 1, 1989·Ophthalmology·A H Weiss, W R Biersdorf
Feb 1, 1994·Australian and New Zealand Journal of Ophthalmology·T J SullivanM A Musarella
Jun 1, 1996·Archives of Ophthalmology·A B FultonD L Mayer
Sep 23, 1997·Archives of Ophthalmology·H J KaplanL V Del Priore
Nov 5, 1997·Nature Genetics·F MarlhensC P Hamel
Mar 14, 1998·Proceedings of the National Academy of Sciences of the United States of America·S L Semple-RowlandW Baehr
Apr 18, 1998·Proceedings of the National Academy of Sciences of the United States of America·H MorimuraT P Dryja
Jul 8, 1998·Proceedings of the National Academy of Sciences of the United States of America·S Mohand-SaidJ A Sahel
Oct 30, 1998·American Journal of Human Genetics·M M SohockiS P Daiger
Nov 3, 1998·Human Genetics·D W StocktonJ R Lupski
Mar 26, 1999·American Journal of Human Genetics·I PerraultJ Kaplan
Oct 3, 1999·Nature Genetics·A I den HollanderA A Bergen
Dec 2, 1999·Nature Genetics·T FurukawaC L Cepko
Apr 15, 2000·Archives of Ophthalmology·A J LoteryE M Stone
Jun 24, 2000·Archives of Ophthalmology·S Mohand-SaidJ A Sahel
Jun 28, 2000·Proceedings of the National Academy of Sciences of the United States of America·J P Van HooserK Palczewski
Jun 30, 2000·Molecular Genetics and Metabolism·M M SohockiS P Daiger
Aug 22, 2000·European Journal of Human Genetics : EJHG·I PerraultJ Kaplan
Mar 20, 2001·Archives of Ophthalmology·A J LoteryE M Stone
Apr 3, 2001·American Journal of Human Genetics·T P DryjaE L Berson
Sep 8, 2001·Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie·K F DamjiR K Koenekoop
Jul 19, 2002·The Journal of Gene Medicine·Fernanda B O PortoJosé Alain Sahel
Oct 11, 2002·Human Molecular Genetics·Dayna T AkeyMelanie M Sohocki
Mar 8, 2003·Ophthalmology·Ann H MilamSamuel G Jacobson

❮ Previous
Next ❯

Citations

Nov 5, 2010·Journal of Ophthalmology·Maria A Musarella, Ian M Macdonald
Sep 15, 2004·Proceedings of the National Academy of Sciences of the United States of America·Xiaoqing LiuTiansen Li
May 27, 2014·Progress in Retinal and Eye Research·Susanne RoosingFrans P M Cremers
Aug 7, 2014·Japanese Journal of Ophthalmology·Takahide SuzukiAkira Murakami
Jan 22, 2010·Journal of Genetics·Hiroshi TomitaMakoto Tamai
Feb 14, 2007·Archives of Ophthalmology·Stephen P DaigerLori S Sullivan
May 2, 2009·Chemical Senses·Paul M JenkinsJeffrey R Martens
Sep 26, 2013·PloS One·Anshuman VermaPeriasamy Sundaresan
Jun 29, 2013·Eye·B S Wallang, S Das
Jul 31, 2012·Human Molecular Genetics·Alejandro Estrada-CuzcanoDorus A Mans
Jan 28, 2009·Ophthalmic Genetics·Moon-Woo SeongSung Sup Park
Dec 3, 2014·The Journal of Molecular Diagnostics : JMD·Moon-Woo SeongSung Sup Park
Mar 20, 2008·Survey of Ophthalmology·John W Gittinger
Mar 4, 2008·Pathology, Research and Practice·Michal Klysik
Dec 3, 2015·European Journal of Human Genetics : EJHG·Galuh D N AstutiFrans P M Cremers
Feb 20, 2007·Ophthalmology·Samuel G JacobsonEdwin M Stone
Oct 1, 2009·Clinical & Experimental Ophthalmology·Monika PradhanAndrea Vincent
Oct 18, 2005·Current Opinion in Cell Biology·Lucia PoggiWilliam A Harris
Dec 17, 2014·Ophthalmic Genetics·Satoshi KatagiriTakeshi Iwata
May 9, 2012·Expert Opinion on Therapeutic Targets·Manisha Anand, Hemant Khanna
Oct 22, 2013·Seminars in Ophthalmology·Miriam EhrenbergAnne B Fulton
Sep 4, 2007·Vision Research·Ronald M HansenAnne B Fulton
Jun 23, 2015·Journal of Ophthalmology·Katsuhiro HosonoYoshihiro Hotta
Jul 18, 2008·Progress in Retinal and Eye Research·Anneke I den HollanderFrans P M Cremers
Feb 12, 2015·Human Gene Therapy. Clinical Development·Simon M Petersen-Jones, András M Komáromy
Dec 31, 2014·Human Gene Therapy. Clinical Development·Simon Petersen-Jones, Andras M Komaromy
Aug 26, 2014·Animal Biotechnology·Viera KolesárováJán Dianovský
Jul 6, 2014·The British Journal of Ophthalmology·Arif O KhanHanno J Bolz
Jan 17, 2009·Current Topics in Developmental Biology·Dyke P McEwenJeffrey R Martens

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adherens Junctions

An adherens junction is defined as a cell junction whose cytoplasmic face is linked to the actin cytoskeleton. They can appear as bands encircling the cell (zonula adherens) or as spots of attachment to the extracellular matrix (adhesion plaques). Adherens junctions uniquely disassemble in uterine epithelial cells to allow the blastocyst to penetrate between epithelial cells. Discover the latest research on adherens junctions here.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Ataxias

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on different types of ataxias here.

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Ataxias (MDS)

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Ataxia

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Batten Disease

Batten Disease is a group of nervous system disorders known as neuronal ceroid lipofuscinosis. This feed focuses on neurobiological and neuropathological aspects of this disease.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

© 2022 Meta ULC. All rights reserved